Top

01-01-2016 | Osteoporosis | Book Chapter | Article

Osteoporosis and Mechanisms of Skeletal Aging

Authors: Julie Glowacki, Ph.D., Tamara Vokes, M.D.

Publisher: Springer International Publishing

Abstract

Osteoporosis is a generalized skeletal disorder in which decreases in bone mass and bone quality lead to increased bone fragility and contribute to risk of fracture. It can affect people at any age, but its prevalence and clinical consequences increase exponentially with age. Fractures are particularly detrimental in the elderly population because they may lead to decreased quality of life, loss of independent living, a decline in health status, and death. Skeletal aging has been a subject of extensive research, with gradual uncovering of mechanisms mediating the loss of bone strength. Among these are bone matrix alterations, genetic and epigenetic mechanisms, age-related changes in bone metabolism and stem cells, declines in osteotrophic hormones, and changes in inflammatory and stress processes. Clinical and epidemiologic studies have also contributed to our understanding of fracture pathophysiology by identifying the risk factors for fractures and their interactions with aging. In addition, management of osteoporosis in the elderly has advanced through the development of an array of therapeutic agents with documented anti-fracture efficacy. Finally, it has become increasingly clear that the most effective approach to fracture prevention includes not just use of pharmacologic agents but addressing the whole patient through appropriate diet, activity, and overall health optimization. A growing understanding of the biological processes of aging and cross-talk between different tissues and organ system offers new approaches to prevent and treat osteoporosis. It is likely that the future of geriatric care will be transformed through a better integration of clinical observations and basic science discoveries.

Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res 22(3):465–475PubMed

Sambrook P, Cooper C (2006) Osteoporosis. Lancet 367(9527):2010–2018PubMed

Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S et al (2014) Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int 25(10):2359–2381PubMedCentralPubMed

Abrahamsen B, van Staa T, Ariely R, Olson M, Cooper C (2009) Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos Int 20(10):1633–1650PubMed

Haentjens P, Magaziner J, Colon-Emeric CS, Vanderschueren D, Milisen K, Velkeniers B et al (2010) Meta-analysis: excess mortality after hip fracture among older women and men. Ann Intern Med 152(6):380–390PubMedCentralPubMed

Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet 359(9319):1761–1767PubMed

Kado DM, Browner WS, Palermo L, Nevitt MC, Genant HK, Cummings SR (1999) Vertebral fractures and mortality in older women: a prospective study. Study of Osteoporotic Fractures Research Group. Arch Intern Med 159(11):1215–1220PubMed

Kado DM, Duong T, Stone KL, Ensrud KE, Nevitt MC, Greendale GA et al (2003) Incident vertebral fractures and mortality in older women: a prospective study. Osteoporos Int 14(7):589–594PubMed

Kado DM, Prenovost K, Crandall C (2007) Narrative review: hyperkyphosis in older persons. Ann Intern Med 147(5):330–338PubMed

10.

Katzman WB, Huang MH, Lane NE, Ensrud KE, Kado DM (2013) Kyphosis and decline in physical function over 15 years in older community-dwelling women: the Study of Osteoporotic Fractures. J Gerontol A Biol Sci Med Sci 68(8):976–983PubMedCentralPubMed

11.

Singer A, Exuzides A, Spangler L, O’Malley C, Colby C, Johnston K et al (2015) Burden of illness for osteoporotic fractures compared with other serious diseases among postmenopausal women in the United States. Mayo Clin Proc 90(1):53–62PubMed

12.

Cauley JA, Chalhoub D, Kassem AM, Fuleihan GH (2014) Geographic and ethnic disparities in osteoporotic fractures. Nat Rev Endocrinol 10(6):338–351PubMed

13.

O’Neill TW, Felsenberg D, Varlow J, Cooper C, Kanis JA, Silman AJ (1996) The prevalence of vertebral deformity in european men and women: the European Vertebral Osteoporosis Study. J Bone Miner Res 11(7):1010–1018PubMed

14.

Chen P, Krege JH, Adachi JD, Prior JC, Tenenhouse A, Brown JP et al (2009) Vertebral fracture status and the World Health Organization risk factors for predicting osteoporotic fracture risk. J Bone Miner Res 24(3):495–502PubMed

15.

Karlsson MK, Ribom EL, Nilsson JA, Karlsson C, Coster M, Vonschewelov T et al (2014) International and ethnic variability of falls in older men. Scand J Public Health 42(2):194–200PubMed

16.

Morrison A, Fan T, Sen SS, Weisenfluh L (2013) Epidemiology of falls and osteoporotic fractures: a systematic review. Clinicoecon Outcomes Res 5:9–18PubMedCentralPubMed

17.

Ballane G, Cauley JA, Luckey MM, Fuleihan GH (2014) Secular trends in hip fractures worldwide: opposing trends East versus West. J Bone Miner Res 29(8):1745–1755PubMed

18.

Khosla S (2013) Pathogenesis of age-related bone loss in humans. J Gerontol A Biol Sci Med Sci 68(10):1226–1235PubMedCentralPubMed

19.

Seeman E (1999) The structural basis of bone fragility in men. Bone 25(1):143–147PubMed

20.

Clarke BL, Khosla S (2010) Physiology of bone loss. Radiol Clin North Am 48(3):483–495PubMedCentralPubMed

21.

Kannegaard PN, van der Mark S, Eiken P, Abrahamsen B (2010) Excess mortality in men compared with women following a hip fracture. National analysis of comedications, comorbidity and survival. Age Ageing 39(2):203–209PubMed

22.

Di Monaco M, Castiglioni C, Vallero F, Di Monaco R, Tappero R (2012) Sarcopenia is more prevalent in men than in women after hip fracture: a cross-sectional study of 591 inpatients. Arch Gerontol Geriatr 55(2):e48–e52PubMed

23.

Di Monaco M, Castiglioni C, Vallero F, Di Monaco R, Tappero R (2012) Men recover ability to function less than women do: an observational study of 1094 subjects after hip fracture. Am J Phys Med Rehabil 91(4):309–315PubMed

24.

Watts NB, Adler RA, Bilezikian JP, Drake MT, Eastell R, Orwoll ES et al (2012) Osteoporosis in men: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 97(6):1802–1822PubMed

25.

Geusens PP, van den Bergh JP (2012) Bone: new guidelines for multistep fracture prevention in men. Nat Rev Rheumatol 8(10):568–570PubMed

26.

Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N (1994) The diagnosis of osteoporosis. J Bone Miner Res 9(8):1137–1141PubMed

27.

Rizzoli R, Branco J, Brandi ML, Boonen S, Bruyere O, Cacoub P et al (2014) Management of osteoporosis of the oldest old. Osteoporos Int 25(11):2507–2529PubMed

28.

Berry SD, Ngo L, Samelson EJ, Kiel DP (2010) Competing risk of death: an important consideration in studies of older adults. J Am Geriatr Soc 58(4):783–787PubMedCentralPubMed

29.

Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E (2008) FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 19(4):385–397PubMedCentralPubMed

30.

Compston J, Bowring C, Cooper A, Cooper C, Davies C, Francis R et al (2013) Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: national Osteoporosis Guideline Group (NOGG) update 2013. Maturitas 75(4):392–396PubMed

31.

Lindsay R, Silverman SL, Cooper C, Hanley DA, Barton I, Broy SB et al (2001) Risk of new vertebral fracture in the year following a fracture. JAMA 285(3):320–323PubMed

32.

Ross PD, Genant HK, Davis JW, Miller PD, Wasnich RD (1993) Predicting vertebral fracture incidence from prevalent fractures and bone density among non-black, osteoporotic women. Osteoporos Int 3(3):120–126PubMed

33.

Siris ES, Genant HK, Laster AJ, Chen P, Misurski DA, Krege JH (2007) Enhanced prediction of fracture risk combining vertebral fracture status and BMD. Osteoporos Int 18(6):761–770PubMed

34.

Donaldson MG, Palermo L, Schousboe JT, Ensrud KE, Hochberg MC, Cummings SR (2009) FRAX and risk of vertebral fractures: the fracture intervention trial. J Bone Miner Res 24(11):1793–1799PubMed

35.

Fink HA, Milavetz DL, Palermo L, Nevitt MC, Cauley JA, Genant HK et al (2005) What proportion of incident radiographic vertebral deformities is clinically diagnosed and vice versa? J Bone Miner Res 20(7):1216–1222PubMed

36.

Lewiecki EM, Laster AJ (2006) Clinical review: clinical applications of vertebral fracture assessment by dual-energy x-ray absorptiometry. J Clin Endocrinol Metab 91(11):4215–4222PubMed

37.

Ensrud KE, Schousboe JT (2011) Clinical practice. Vertebral fractures. N Engl J Med 364(17):1634–1642PubMed

38.

Rosen HN, Vokes TJ, Malabanan AO, Deal CL, Alele JD, Olenginski TP et al (2013) The Official Positions of the International Society for Clinical Densitometry: vertebral fracture assessment. J Clin Densitom 16(4):482–488PubMed

39.

Tinetti ME, Speechley M, Ginter SF (1988) Risk factors for falls among elderly persons living in the community. N Engl J Med 319(26):1701–1707PubMed

40.

Peel NM, Kassulke DJ, McClure RJ (2002) Population based study of hospitalised fall related injuries in older people. Inj Prev 8(4):280–283PubMedCentralPubMed

41.

Rodriguez-Manas L (2014) Fried LP. Frailty in the clinical scenario, Lancet

42.

Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J et al (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56(3):M146–M156PubMed

43.

Ensrud KE, Ewing SK, Taylor BC, Fink HA, Cawthon PM, Stone KL et al (2008) Comparison of 2 frailty indexes for prediction of falls, disability, fractures, and death in older women. Arch Intern Med 168(4):382–389PubMed

44.

Ensrud KE, Ewing SK, Taylor BC, Fink HA, Stone KL, Cauley JA et al (2007) Frailty and risk of falls, fracture, and mortality in older women: the study of osteoporotic fractures. J Gerontol A Biol Sci Med Sci 62(7):744–751PubMed

45.

Tom SE, Adachi JD, Anderson FA Jr, Boonen S, Chapurlat RD, Compston JE et al (2013) Frailty and fracture, disability, and falls: a multiple country study from the global longitudinal study of osteoporosis in women. J Am Geriatr Soc 61(3):327–334PubMedCentralPubMed

46.

Kaiser MJ, Bauer JM, Ramsch C, Uter W, Guigoz Y, Cederholm T et al (2010) Frequency of malnutrition in older adults: a multinational perspective using the mini nutritional assessment. J Am Geriatr Soc 58(9):1734–1738PubMed

47.

Genaro Pde S, Martini LA (2010) Effect of protein intake on bone and muscle mass in the elderly. Nutr Rev 68(10):616–623PubMed

48.

Waters DL, Baumgartner RN, Garry PJ, Vellas B (2010) Advantages of dietary, exercise-related, and therapeutic interventions to prevent and treat sarcopenia in adult patients: an update. Clin Interv Aging 5:259–270PubMedCentralPubMed

49.

Livingstone C (2013) Insulin-like growth factor-I (IGF-I) and clinical nutrition. Clin Sci (Lond) 125(6):265–280

50.

Wijnhoven HA, Schilp J, van Bokhorst-de van der Schueren MA, de Vet HC, Kruizenga HM, Deeg DJ et al (2012) Development and validation of criteria for determining undernutrition in community-dwelling older men and women: the Short Nutritional Assessment Questionnaire 65+. Clin Nutr 31(3):351–358PubMed

51.

Chevalley T, Hoffmeyer P, Bonjour JP, Rizzoli R (2010) Early serum IGF-I response to oral protein supplements in elderly women with a recent hip fracture. Clin Nutr 29(1):78–83PubMed

52.

Gaffney-Stomberg E, Insogna KL, Rodriguez NR, Kerstetter JE (2009) Increasing dietary protein requirements in elderly people for optimal muscle and bone health. J Am Geriatr Soc 57(6):1073–1079PubMed

53.

Mithal A, Bonjour JP, Boonen S, Burckhardt P, Degens H, El Hajj FG et al (2013) Impact of nutrition on muscle mass, strength, and performance in older adults. Osteoporos Int 24(5):1555–1566PubMed

54.

Compston JE, Watts NB, Chapurlat R, Cooper C, Boonen S, Greenspan S et al (2011) Obesity is not protective against fracture in postmenopausal women: GLOW. Am J Med 124(11):1043–1050PubMed

55.

Nielson CM, Srikanth P, Orwoll ES (2012) Obesity and fracture in men and women: an epidemiologic perspective. J Bone Miner Res 27(1):1–10PubMed

56.

Premaor M, Parker RA, Cummings S, Ensrud K, Cauley JA, Lui LY et al (2013) Predictive value of FRAX for fracture in obese older women. J Bone Miner Res 28(1):188–195PubMedCentralPubMed

57.

Nielson CM, Marshall LM, Adams AL, LeBlanc ES, Cawthon PM, Ensrud K et al (2011) BMI and fracture risk in older men: the osteoporotic fractures in men study (MrOS). J Bone Miner Res 26(3):496–502PubMedCentralPubMed

58.

Leslie WD, Orwoll ES, Nielson CM, Morin SN, Majumdar SR, Johansson H et al (2014) Estimated lean mass and fat mass differentially affect femoral bone density and strength index but are not FRAX independent risk factors for fracture. J Bone Miner Res 29(11):2511–2519PubMed

59.

Bolland MJ, Grey A, Avenell A, Gamble GD, Reid IR (2011) Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women’s Health Initiative limited access dataset and meta-analysis. BMJ 342:d2040PubMedCentralPubMed

60.

Prentice RL, Pettinger MB, Jackson RD, Wactawski-Wende J, Lacroix AZ, Anderson GL et al (2013) Health risks and benefits from calcium and vitamin D supplementation: women’s Health Initiative clinical trial and cohort study. Osteoporos Int 24(2):567–580PubMedCentralPubMed

61.

Steingrimsdottir L, Gunnarsson O, Indridason OS, Franzson L, Sigurdsson G (2005) Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. JAMA 294(18):2336–2341PubMed

62.

Boucher BJ (2012) The problems of vitamin d insufficiency in older people. Aging Dis 3(4):313–329PubMedCentralPubMed

63.

Abellan van Kan G, Rolland Y, Houles M, Gillette-Guyonnet S, Soto M, Vellas B (2010) The assessment of frailty in older adults. Clin Geriatr Med 26(2):275–286PubMed

64.

Kado DM, Miller-Martinez D, Lui LY, Cawthon P, Katzman WB, Hillier TA et al (2014) Hyperkyphosis, kyphosis progression, and risk of non-spine fractures in older community dwelling women: the study of osteoporotic fractures (SOF). J Bone Miner Res 29(10):2210–2216PubMedCentralPubMed

65.

Katzman WB, Harrison SL, Fink HA, Marshall LM, Orwoll E, Barrett-Connor E et al (2014) Physical function in older Men with hyperkyphosis. J Gerontol A Biol Sci Med Sci 70(5):635–40PubMed

66.

Bansal S, Katzman WB, Giangregorio LM (2014) Exercise for improving age-related hyperkyphotic posture: a systematic review. Arch Phys Med Rehabil 95(1):129–140PubMedCentralPubMed

67.

Michael YL, Whitlock EP, Lin JS, Fu R, O’Connor EA, Gold R (2010) Primary care-relevant interventions to prevent falling in older adults: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med 153(12):815–825PubMed

68.

Howe TE, Shea B, Dawson LJ, Downie F, Murray A, Ross C et al (2011) Exercise for preventing and treating osteoporosis in postmenopausal women. Cochrane Database Syst Rev 7, CD000333PubMed

69.

Robertson MC, Campbell AJ, Gardner MM, Devlin N (2002) Preventing injuries in older people by preventing falls: a meta-analysis of individual-level data. J Am Geriatr Soc 50(5):905–911PubMed

70.

Sherrington C, Henschke N (2013) Why does exercise reduce falls in older people? Unrecognised contributions to motor control and cognition? Br J Sports Med 47(12):730–731PubMed

71.

Giangregorio LM, Papaioannou A, Macintyre NJ, Ashe MC, Heinonen A, Shipp K et al (2014) Too Fit To Fracture: exercise recommendations for individuals with osteoporosis or osteoporotic vertebral fracture. Osteoporos Int 25(3):821–835PubMed

72.

Li F, Harmer P, Fisher KJ, McAuley E, Chaumeton N, Eckstrom E et al (2005) Tai Chi and fall reductions in older adults: a randomized controlled trial. J Gerontol A Biol Sci Med Sci 60(2):187–194PubMed

73.

Wayne PM, Kiel DP, Buring JE, Connors EM, Bonato P, Yeh GY et al (2012) Impact of Tai Chi exercise on multiple fracture-related risk factors in post-menopausal osteopenic women: a pilot pragmatic, randomized trial. BMC Complement Altern Med 12:7PubMedCentralPubMed

74.

Ensrud KE, Black DM, Palermo L, Bauer DC, Barrett-Connor E, Quandt SA et al (1997) Treatment with alendronate prevents fractures in women at highest risk: results from the Fracture Intervention Trial. Arch Intern Med 157(22):2617–2624PubMed

75.

Boonen S, Black DM, Colon-Emeric CS, Eastell R, Magaziner JS, Eriksen EF et al (2010) Efficacy and safety of a once-yearly intravenous zoledronic acid 5 mg for fracture prevention in elderly postmenopausal women with osteoporosis aged 75 and older. J Am Geriatr Soc 58(2):292–299PubMedCentralPubMed

76.

Boonen S, Marin F, Mellstrom D, Xie L, Desaiah D, Krege JH et al (2006) Safety and efficacy of teriparatide in elderly women with established osteoporosis: bone anabolic therapy from a geriatric perspective. J Am Geriatr Soc 54(5):782–789PubMed

77.

Boonen S, McClung MR, Eastell R, El-Hajj Fuleihan G, Barton IP, Delmas P (2004) Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: implications for the use of antiresorptive agents in the old and oldest old. J Am Geriatr Soc 52(11):1832–1839PubMed

78.

McClung MR, Geusens P, Miller PD, Zippel H, Bensen WG, Roux C et al (2001) Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med 344(5):333–340PubMed

79.

Seeman E, Vellas B, Benhamou C, Aquino JP, Semler J, Kaufman JM et al (2006) Strontium ranelate reduces the risk of vertebral and nonvertebral fractures in women eighty years of age and older. J Bone Miner Res 21(7):1113–1120PubMed

80.

Hochberg MC, Thompson DE, Black DM, Quandt SA, Cauley J, Geusens P et al (2005) Effect of alendronate on the age-specific incidence of symptomatic osteoporotic fractures. J Bone Miner Res 20(6):971–976PubMed

81.

Boonen S, Adachi JD, Man Z, Cummings SR, Lippuner K, Torring O et al (2011) Treatment with denosumab reduces the incidence of new vertebral and hip fractures in postmenopausal women at high risk. J Clin Endocrinol Metab 96(6):1727–1736PubMed

82.

Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA et al (2007) Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 356(18):1809–1822PubMed

83.

Black DM, Thompson DE, Bauer DC, Ensrud K, Musliner T, Hochberg MC et al (2000) Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group. J Clin Endocrinol Metab 85(11):4118–4124PubMed

84.

Boonen S, Orwoll E (2013) Fracture risk and zoledronic acid in men with osteoporosis. N Engl J Med 368(9):873PubMed

85.

Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR et al (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361(8):756–765PubMed

86.

Maricic M, Adachi JD, Sarkar S, Wu W, Wong M, Harper KD (2002) Early effects of raloxifene on clinical vertebral fractures at 12 months in postmenopausal women with osteoporosis. Arch Intern Med 162(10):1140–1143PubMed

87.

Meunier PJ, Roux C, Seeman E, Ortolani S, Badurski JE, Spector TD et al (2004) The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 350(5):459–468PubMed

88.

Roux C, Seeman E, Eastell R, Adachi J, Jackson RD, Felsenberg D et al (2004) Efficacy of risedronate on clinical vertebral fractures within six months. Curr Med Res Opin 20(4):433–439PubMed

89.

Hlaing TT, Compston JE (2014) Biochemical markers of bone turnover – uses and limitations. Ann Clin Biochem 51(Pt 2):189–202PubMed

90.

Vasikaran S, Eastell R, Bruyere O, Foldes AJ, Garnero P, Griesmacher A et al (2011) Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int 22(2):391–420PubMed

91.

Naylor K, Eastell R (2012) Bone turnover markers: use in osteoporosis. Nat Rev Rheumatol 8(7):379–389PubMed

92.

Watts NB, Bilezikian JP (2014) Advances in target-specific therapy for osteoporosis. J Clin Endocrinol Metab 99(4):1149–1151PubMed

93.

Vashishth D (2007) The role of the collagen matrix in skeletal fragility. Curr Osteoporos Rep 5:62–66PubMed

94.

Jepsen KJ (2003) The aging cortex: to crack or not to crack. Osteoporos Int 14(Suppl 5):S57–S62PubMed

95.

Currey JD, Brear K, Zioupos P (1996) The effects of ageing and changes in mineral content in degrading the toughness of human femora. J Biomech 29:257–260PubMed

96.

Zimmermann EA, Schaible E, Bale H et al (2011) Age-related changes in the plasticity and toughness of human cortical bone at multiple length scales. Proc Natl Acad Sci U S A 108:14416–14421PubMedCentralPubMed

97.

Paschalis EP, Tatakis DN, Robins S et al (2011) Lathyrism-induced alterations in collagen cross-links influence the mechanical properties of bone material without affecting the mineral. Bone 49:1232–1241PubMedCentralPubMed

98.

Wang X, Bank RA, TeKoppele JM, Agrawal CM (2001) The role of collagen in determining bone mechanical properties. J Orthop Res 19:1021–1026PubMed

99.

Vashishth D, Gibson GJ, Khoury JI et al (2001) Influence of nonenzymatic glycation on biomechanical properties of cortical bone. Bone 28:195–201PubMed

100.

Leslie RD, Beyan H, Sawtell P, Boehm BO, Spector TD, Snieder H (2003) Level of an advanced glycated end product is genetically determined: a study of normal twins. Diabetes 52:2441–2444PubMed

101.

Saito M, Marumo K (2010) Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus. Osteoporos Int 21:195–214PubMed

102.

Hein G, Wiegand R, Lehmann G, Stein G, Franke S (2003) Advanced glycation end-products pentosidine and N epsilon-carboxymethyllysine are elevated in serum of patients with osteoporosis. Rheumatology (Oxford) 42:1242–1246

103.

Bonar LC, Roufousse AS, Sabine WK et al (1983) X-ray diffraction studies of the crystallinity of bone mineral in newly synthesized and density fractionated bone. Calcif Tissue Int 35:202–209PubMed

104.

Paschalis EP, DiCarlo E, Betts F et al (1996) FTIR microspectroscopic analysis of human osteonal bone. Calcif Tissue Int 59:480–487PubMed

105.

Simmons ED Jr, Pritzker KPH, Grynpas MD (1991) Age-related changes in the human femoral cortex. J Orthop Res 9:155–167PubMed

106.

Burr DB, Turner CH (1999) Biomechanical measurements in age-related bone loss. In: Rosen CJ, Glowacki J, Bilezikian JP (eds) The aging skeleton. Academic, San Diego, pp 301–311

107.

Kleerekoper M, Villanueva AR, Stanciu J, Rao DS, Parfitt AM (1985) The role of three-dimensional trabecular microstructure in the pathogenesis of vertebral compression fractures. Calcif Tissue Int 37:594–597PubMed

108.

Gabet Y, Bab I (2011) Microarchitectural changes in the aging skeleton. Curr Osteoporos Rep 9:177–183PubMed

109.

Chen H, Zhou X, Shoumura S, Emura S, Bunai Y (2010) Age- and gender-dependent changes in three-dimensional microstructure of cortical and trabecular bone at the human femoral neck. Osteoporos Int 21:627–636PubMed

110.

Martin RB (1991) Determinants of the mechanical properties of bones. J Biomech ;24 Suppl 1:79–88. Review. Erratum in: J Biomech. 1992;25:1251

111.

Boyde A (2002) Morphologic detail of aging bone in human vertebrae. Endocrine 17:5–14PubMed

112.

Schaffler MB, Choi K, Milgrom C (1995) Aging and matrix microdamage accumulation in human compact bone. Bone 17:521–525PubMed

113.

Lambers FM, Bouman AR, Rimnac CM, Hernandez CJ (2013) Microdamage caused by fatigue loading in human cancellous bone: relationship to reductions in bone biomechanical performance. PLoS One 8, e83662PubMedCentralPubMed

114.

Frost HM (1991) Some ABC’s of skeletal pathophysiology. 5. Microdamage physiology. Calcif Tissue Int 49:229–231PubMed

115.

Noble B (2003) Bone microdamage and cell apoptosis. Eur Cell Mater 6:46–55PubMed

116.

Burr DB, Martin RB, Schaffler MB, Radin EL (1985) Bone remodeling in response to in vivo fatigue microdamage. J Biomech 18:189–200PubMed

117.

Kennedy OD, Herman BC, Laudier DM et al (2012) Activation of resorption in fatigue-loaded bone involves both apoptosis and active pro-osteoclastogenic signaling by distinct osteocyte populations. Bone 50:1115–1122PubMedCentralPubMed

118.

Seref-Ferlengez Z, Basta-Pljakic J, Kennedy OD, Philemon CJ, Schaffler MB (2014) Structural and mechanical repair of diffuse damage in cortical bone in vivo. J Bone Miner Res 29:2537–2544PubMed

119.

Lips P, Courpron P, Meunier PJ (1978) Mean wall thickness of trabecular bone packets in the human iliac crest: changes with age. Calcif Tissue Res 26:13–17PubMed

120.

Miyata T, Notoya K, Yoshida K et al (1997) Advanced glycation end products enhance osteoclast-induced bone resorption in cultured mouse unfractionated bone cells and in rats implanted subcutaneously with devitalized bone particles. J Am Soc Nephrol 8:260–270PubMed

121.

Chung PL, Zhou S, Eslami B, Shen L, LeBoff MS, Glowacki J (2014) Effect of age on regulation of human osteoclast differentiation. J Cell Biochem 115:1412–1419PubMedCentralPubMed

122.

Cheleuitte D, Mizuno S, Glowacki J (1998) In vitro secretion of cytokines by human bone marrow: effects of age and estrogen status. J Clin Endocrinol Metab 83:2043–2051PubMed

123.

Eslami B, Zhou S, Van Eekeren I, LeBoff MS, Glowacki J (2011) Reduced osteoclastogenesis and RANKL expression in marrow from women taking alendronate. Calcif Tissue Int 88:272–280PubMedCentralPubMed

124.

Mueller SM, Glowacki J (2001) Age-related decline in the osteogenic potential of human bone marrow cells cultured in three-dimensional collagen sponges. J Cell Biochem 82:583–590PubMed

125.

Zhou S, Greenberger JS, Epperly MW et al (2008) Age-related intrinsic changes in human marrow stromal cells and their differentiation to osteoblasts. Aging Cell 7:335–343PubMedCentralPubMed

126.

D’Ippolito G, Schiller PC, Ricordi C, Roos BA, Howard GA (1999) Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J Bone Miner Res 14:1115–1122PubMed

127.

Shen L, Zhou S, Glowacki J (2009) Effects of age and gender on WNT gene expression in human bone marrow stromal cells. J Cell Biochem 106:337–343PubMedCentralPubMed

128.

Pandey AC, Semon JA, Kaushal D et al (2011) MicroRNA profiling reveals age-dependent differential expression of nuclear factor κB and mitogen-activated protein kinase in adipose and bone marrow-derived human mesenchymal stem cells. Stem Cell Res Ther 2:49PubMedCentralPubMed

129.

Candini O, Spano C, Murgia A, et al. Mesenchymal progenitors aging highlights a miR-196 switch targeting HOXB7 as master regulator of proliferation and osteogenesis. Stem Cells. 2014 Nov 26. doi: 10.1002/stem.1897. [Epub ahead of print]

130.

Zhou S, Bueno EM, Kim SW et al (2011) Effects of age on parathyroid hormone signaling in human marrow stromal cells. Aging Cell 10:780–788PubMedCentralPubMed

131.

Geng S, Zhou S, Glowacki J (2011) Age-related decline in osteoblastogenesis and 1α-hydroxylase/CYP27B1 in human mesenchymal stem cells: stimulation by parathyroid hormone. Aging Cell 10:962–971PubMedCentralPubMed

132.

Zhou S, Geng S, Glowacki J (2013) Histone deacetylation mediates the rejuvenation of osteoblastogenesis by the combination of 25(OH)D3 and parathyroid hormone in MSCs from elders. J Steroid Biochem Mol Biol 136:156–159PubMedCentralPubMed

133.

Geng S, Zhou S, Bi Z, Glowacki J (2013) Vitamin D metabolism in human bone marrow stromal (mesenchymal stem) cells. Metabolism 62:768–777PubMedCentralPubMed

134.

D’Avis PY, Frazier CR, Shapiro JR, Fedarko NS (1997) Age-related changes in effects of insulin-like growth factor I on human osteoblast-like cells. Biochem J 324:753–760PubMedCentralPubMed

135.

Haden ST, Glowacki J, Hurwitz S, Rosen C, LeBoff MS (2000) Effects of age on serum dehydroepiandrosterone sulfate, IGF-I, and IL-6 levels in women. Calcif Tissue Int 66:414–418PubMed

136.

Gordon CM, LeBoff MS, Glowacki J (2001) Adrenal and gonadal steroids inhibit IL-6 secretion by human marrow cells. Cytokine 16:178–186PubMed

137.

Kennedy BK, Berger SL, Brunet A et al (2014) Geroscience: linking aging to chronic disease. Cell 159:709–713PubMed

138.

López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G (2013) The hallmarks of aging. Cell 153:1194–1217PubMedCentralPubMed

139.

Marie PJ (2014) Bone cell senescance:Mechanisms and perspectives. J Bone Miner Res 29:1311–1321PubMed

140.

Shiraki M, Aoki C, Goto M (1998) Bone and calcium metabolism in Werner’s syndrome. Endocr J 45:505–512PubMed

141.

Simonsen JL, Rosada C, Serakinci N et al (2002) Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat Biotechnol 20:592–596PubMed

142.

Bork S, Pfister S, Witt H et al (2010) DNA methylation pattern changes upon long-term culture and aging of human mesenchymal stromal cells. Aging Cell 9:54–63PubMedCentralPubMed

143.

Yu KR, Kang KS (2013) Aging-related genes in mesenchymal stem cells: a mini-review. Gerontology 59:557–563PubMed

144.

Zhu Y, Song X, Wang J et al (2015) Placental mesenchymal stem cells of fetal origin deposit epigenetic alterations during long-term culture under serum-free condition. Expert Opin Biol Ther 15:163–180PubMed

145.

Garrett IR, Chen D, Gutierrez G et al (2003) Selective inhibitors of the osteoblast proteasome stimulate bone formation in vivo and in vitro. J Clin Invest 111:1771–1782PubMedCentralPubMed

146.

Nuschke A, Rodrigues M, Stolz DB et al (2014) Human mesenchymal stem cells/multipotent stromal cells consume accumulated autophagosomes early in differentiation. Stem Cell Res Ther 5:140e

147.

Alessio N, Del Gaudio S, Capasso S et al (2015) Low dose radiation induced senescence of human mesenchymal stromal cells and impaired the autophagy process. Oncotarget 6(10):8155–8166PubMedCentralPubMed

148.

Hocking LJ, Whitehouse C, Helfrich MH (2012) Autophagy: a new player in skeletal maintenance? J Bone Miner Res 27:1439–1447PubMed

149.

Mobasheri A, Shakibaei M (2013) Osteogenic effects of resveratrol in vitro: potential for the prevention and treatment of osteoporosis. Ann N Y Acad Sci 1290:59–66PubMed

150.

Kneissel M, Luong-Nguyen NH, Baptist M, Cortesi R, Zumstein-Mecker S, Kossida S, O’Reilly T, Lane H, Susa M (2004) Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts. Bone 35:1144–1156PubMed

151.

Lecka-Czernik B, Stechschulte LA (2014) Bone and fat: a relationship of different shades. Arch Biochem Biophys 561:124–129PubMed

152.

Novotny SA, Warren GL, Hamrick MW (2015) Aging and the muscle-bone relationship. Physiology (Bethesda) 30:8–16

153.

Almeida M, O’Brien CA (2013) Basic biology of skeletal aging: role of stress response pathways. J Gerontol A Biol Sci Med Sci 68:1197–1208PubMedCentralPubMed

154.

Manolagas SC (2010) From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis. Endocr Rev 31:266–300PubMedCentralPubMed

155.

Gokhale A, Rwigema JC, Epperly MW et al (2010) Small molecule GS-nitroxide ameliorates ionizing irradiation-induced delay in bone wound healing in a novel murine model. In Vivo 24:377–385PubMedCentralPubMed

156.

Glowacki J, Mizuno S, Kung J et al (2014) Effects of mouse genotype on bone wound healing and irradiation-induced delay of healing. In Vivo 28:189–196PubMed

157.

Franceschi C, Campisi J (2014) Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci 69:S4–S9PubMed

158.

Sanguineti R, Puddu A, Mach F, Montecucco F, Viviani GL (2014) Advanced glycation end products play adverse proinflammatory activities in osteoporosis. Mediators Inflamm 2014:975872PubMedCentralPubMed

159.

Feng X, Feng G, Xing J et al (2014) Repeated lipopolysaccharide stimulation promotes cellular senescence in human dental pulp stem cells (DPSCs). Cell Tissue Res 356:369–380PubMed

160.

Abdelmagid SM, Barbe MF, Safadi FF. Role of inflammation in the aging bone. Life Sci. 2014 Dec 12. pii: S0024-3205(14)00932-1 [Epub ahead of print].

161.

Glowacki J, Zhou S (2013) The role of inflammation in senescence of human MSCs. J Bone Miner Res 28:S80

162.

Severino V, Alessio N, Farina A et al (2013) Insulin-like growth factor binding proteins 4 and 7 released by senescent cells promote premature senescence in mesenchymal stem cells. Cell Death Dis 4, e911PubMedCentralPubMed

163.

Jin HJ, Bae YK, Kim M et al (2013) Comparative analysis of human mesenchymal stem cells from bone marrow, adipose tissue, and umbilical cord blood as sources of cell therapy. Int J Mol Sci 14:17986–18001PubMedCentralPubMed

164.

Bellayr IH, Catalano JG, Lababidi S et al (2014) Gene markers of cellular aging in human multipotent stromal cells in culture. Stem Cell Res Ther 5:59e

165.

Cmielova J, Havelek R, Soukup T et al (2012) Gamma radiation induces senescence in human adult mesenchymal stem cells from bone marrow and periodontal ligaments. Int J Radiat Biol 88:393–404PubMed

166.

Takeda T (1999) Senescence-accelerated mouse (SAM): a biogerontological resource in aging research. Neurobiol Aging 20:105–110PubMed

167.

Kuro-o M, Matsumura Y, Aizawa H et al (1997) Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390:45–51PubMed

168.

Maddatu TP, Grubb SC, Bult CJ, Bogue MA (2012) Mouse Phenome Database (MPD). Nucleic Acids Res 40(Database issue):D887–D894PubMedCentralPubMed

169.

Beamer WG, Donahue LR, Rosen CJ, Baylink DJ (1996) Genetic variability in adult bone density among inbred strains of mice. Bone 18:397–403PubMed

170.

Jilka RL (2013) The relevance of mouse models for investigating age-related bone loss in humans. J Gerontol A Biol Sci Med Sci 68:1209–1217PubMedCentralPubMed

171.

Harrison DE, Archer JR (1987) Genetic differences in effects of food restriction on aging in mice. J Nutr 117:376–382PubMed

172.

Forster MJ, Morris P, Sohal RS (2003) Genotype and age influence the effect of caloric intake on mortality in mice. FASEB J 17:690–692PubMedCentralPubMed

173.

Liao CY, Rikke BA, Johnson TE, Diaz V, Nelson JF (2010) Genetic variation in the murine lifespan response to dietary restriction: from life extension to life shortening. Aging Cell 9:92–95PubMedCentralPubMed

174.

Seok J, Warren HS, Cuenca AG et al (2013) Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A 110:3507–3512PubMedCentralPubMed

175.

Jowsey J (1966) Studies of Haversian systems in man and some animals. J Anat 100:857–864PubMedCentralPubMed

176.

Kharode YP, Sharp MC, Bodine PV (2008) Utility of the ovariectomized rat as a model for human osteoporosis in drug discovery. Methods Mol Biol 455:111–124PubMed

177.

Wahl EC, Aronson J, Liu L et al (2010) Restoration of regenerative osteoblastogenesis in aged mice: modulation of TNF. J Bone Miner Res 25:114–123PubMedCentralPubMed

178.

Grammatikakis I, Panda AC, Abdelmohsen K, Gorospe M (2014) Long noncoding RNAs(lncRNAs) and the molecular hallmarks of aging. Aging (Albany NY) 6:992–1009

Medicine Matters Rheumatology

Abstract